Catalog :




Detail Article

Folia Medica Indonesiana

ISSN 0303-7932

Vol. 41 / No. 1 / Published : 2005-01

TOC : 3, and page :3 - 8

Related with : Scholar   Yahoo!   Bing

Original Article :

The association of mitochondrial dna mutation g3316a and t3394c with diabetes mellitus

Author :

  1. Agung Pranoto*1
  1. Division of Endocrinology & Metabolism Department of Internal Medicine Airlangga University School of Medicine Diabetes & Nutrition Center Dr. Soetomo Teaching Hospital, , Surabaya, Indonesia

Abstract :

Mutation in the mitochondrial DNA (mtDNA) is known as a monogenic causative factor for A3243G mtDNA mutation in the pathomechanism of type 2 diabetes mellitus (T2DM). A point mutation at nucleotide position G3316A and T3394C in the mtDNA NADH dehygrogenase 1 (ND1) gene has been reported in T2DM, categorized as Single Nucleotide Polymorphism (SNP. However, those two SNPs have been also found in normal population. The role of mtDNA mutation is still not yet studied widely among Indonesian population. We therefore investigated the contribution of mtDNA mutation and diabetes mellitus (DM). Blood DNA was screened from 451 of T2DM cases collected from DM patients at Dr. Soetomo Hospital during 2001-2003. The G3316A and T3394C were detected using PCR and digested with HaeIII restriction enzyme. Fortunately, we found two pedigrees harboring G3316A and two pedigrees with T3394C point mutation. Family studies of those pedigrees showed that DM with those G3316A and T3394C had a significant odds ratio 5.2 (95% CI: 1.222-2.,134) and 3.185 (95% CI: 1.025-9.893), respectively, compared to the sample taken from the same social and environmental background. We suggest that there are two types of mtDNA mutation associated with DM. The first is pathogenic mutations that lead to severe defect in oxidative phosphorylation (OXPHOS), represented by A3243G, and thus causal for DM. The second is SNPs that presumably alter tissue capacity for OXPHOS in such a way contributing to the polygenic T2DM as a presponding factor. A conclusion can be made that is G3316A and T3394C are SNPs that have a role as polygenic components to the pathomechanism of DM.

Keyword :

mithocondrial DNA mutation, monogenic, polygenic, diabetes mellitus, maternally inherited, single nucleotide polymorphism, A3243G, G3316A, T3394C,


References :

  1. McCarthy M, Cassell P, Tran T, Mathias L, 't Hart LM, Maassen JA, Snehalatha C, Ramachandran A, Visw, (1996). Evaluation of the importance of maternal history of diabetes and of mitochondrial variation in the development of NIDDM . - : Diabet Med
  2. Morten KJ, Cooper JM, Brown KG, Lake BD, Pike D, Poulton J, (1993). A new point mutation associated with mitochondrial encephalomyopathy . - : Hum Mol Genet


   


Archive Article

Cover Media Content

Volume : 41 / No. : 1 / Pub. : 2005-01
  1. Editorial vol 41 no 1 2005
  2. Opinion: research in the development of medical science and technology
  3. The association of mitochondrial dna mutation g3316a and t3394c with diabetes mellitus
  4. The effects of unilateral testicular torsion upon immunity modulation and apoptosis of germinal cells in the contralateral testis. an experimental study in rats
  5. The effect of 5α reductase inhibitor and estrogen in prostate proliferation. an experimental study in rats
  6. Quality of refilled drinking water in surabaya city
  7. Adequate help for patients with cervical cancer? the referral system in indonesia. a descriptive comparison study in four provinces
  8. In vitro drug sensitivity of trypanosoma evansi bangkalan isolates
  9. Comparison of dead victims due to burn between periods
  10. Serum osmolal gap in healthy persons. comparison of eleven formulas for calculating osmolality
  11. Traumatic optic neuropathy in the division of neuro-ophthalmology, department of ophthalmology, dr soetomo teaching hospital, surabaya
  12. The potential role of α-lipoic acid in the management of diabetes mellitus. possible molecular mechanism
  13. Review article and clinical experience: metabolic syndrome vs insulin resistance syndrome (a cluster of components and strategies for treatment)